AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11704914
Drug: Gd-DTPA (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gd-DTPA (0.1 mmol/kg b. w. as a bolus injection)
Trial: 29346040
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (observation) (per-protocol population)
Trial: 20502739
Drug: Physiological solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiological solution
Trial: 16364549
Drug: Placebo (fake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (fake analgesic cream)
Trial: 8680609
Drug: Insulin resistance
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin resistance assessed using the frequently sampled intravenous glucose tolerance test with minimal model analysis
Trial: 30604599
Drug: Metformin, Sitagliptin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin, Sitagliptin, and Acarbose (Met+Sita+Acarb)
Trial: 30604599
Drug: Metformin and
RxNorm normalized name: metformin and acarbose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin and Sitagliptin (Met+Sita)
Trial: 10068082
Drug: Progesterone receptor
RxNorm normalized name: Progesterone receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Progesterone receptor (PgR) status
Trial: 7736480
Drug: Beta-adrenergic chronic
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-adrenergic chronic therapy
Trial: 3437508
Drug: Trapidil (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trapidil (400 mg daily on days 1 to 8, 200 mg on day 9)
Trial: 31014775
Drug: (−)-epicatechin 1
RxNorm normalized name: EPICATECHIN
DrugBank: Epicatechin (DB12039)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (−)-epicatechin 1 mg/kg BW
Trial: 31014775
Drug: (−)-epicatechin 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (−)-epicatechin 0.5 mg/kg BW
Trial: 31014775
Drug: (−)-epicatechin 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (−)-epicatechin 0.1 mg/kg BW
Trial: 26422126
Drug: Intravenous propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous propranolol (0.15 mg/kg)
Trial: 9161744
Drug: Atracurium (0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atracurium (0.05 mg.kg‐1)
Trial: 8424378
Drug: PPA (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PPA (75 mg osmotic release oral system (OROS)‐PPA/d)
Trial: 3122275
Drug: Misoprostol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misoprostol (400 mcg)
Trial: 27742998
Drug: EP217609 (4,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EP217609 (4, 8, 12 mg)
Trial: 27742998
Drug: Avidin (30-min
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Avidin (30-min intravenous infusion)
Trial: 19687579
Drug: cilnidipine 5-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cilnidipine 5-10 mg/day
Trial: 19687579
Drug: amlodipine 5-7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: amlodipine 5-7.5 mg/day
Trial: 17684620
Drug: L-arginine (7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (7 grams per day for seven days)
Trial: 15110198
Drug: Bivalirudin (0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bivalirudin (0.75 mg/kg bolus, 1.75 mg/kg/hour infusion during the procedure)
Trial: 15110198
Drug: Heparin (70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (70 U/kg initial bolus)
Trial: 3608733
Drug: Arbacet 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arbacet 25 micrograms four times daily
Trial: 27367766
Drug: Standardized rehabilitation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized rehabilitation therapy (SRT)
Trial: 25176376
Drug: 22.63 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 22.63 mg/kg emulsified isoflurane
Trial: 25176376
Drug: 38.26 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 38.26 mg/kg emulsified isoflurane
Trial: 25176376
Drug: 49.73 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 49.73 mg/kg emulsified isoflurane
Trial: 21636188
Drug: Active manuka
RxNorm normalized name: manuka oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active manuka honey 20 ml 4 times daily for 6 weeks
Trial: 21636188
Drug: Placebo (golden
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (golden syrup) 20 ml 4 times daily for 6 weeks
Trial: 21636188
Drug: Active manuka
RxNorm normalized name: manuka oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active manuka honey and Placebo (golden syrup)
Trial: 21029641
Drug: Shenfu injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shenfu injection (SF injection) administered by peripheral intravenous infusion at initially 0.2 ml/kg and then 0.8 ml (kg/h) until the end of operations
Trial: 21029641
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline (Group N) administered similarly
Trial: 21029641
Drug: Shenfu injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shenfu injection (SF injection)
Trial: 18684185
Drug: Single-dose lubiprostone
RxNorm normalized name: Lubiprostone
DrugBank: Lubiprostone (DB01046)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-dose lubiprostone (24 microg)
Trial: 10415055
Drug: anti-TNF-alpha therapy
RxNorm normalized name: anti-interleukin-1.alpha. immunoglobulin G rabbit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: anti-TNF-alpha therapy
Trial: 7594063
Drug: Propionyl-L-carnitine (n
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propionyl-L-carnitine (n = 99)
Trial: 7594063
Drug: Propionyl-L-carnitine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propionyl-L-carnitine (2 g/day)
Trial: 2255726
Drug: 1.5 g
RxNorm normalized name: Vaporizer Vicks 1.5 gal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 g POT II in a high-protein soup vehicle (70 kcal)
Trial: 28107852
Drug: Topical chamomile
RxNorm normalized name: Chamomile
DrugBank: Chamomile (DB14357)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical chamomile oil
Trial: 21116816
Drug: Acetaminophen 650
RxNorm normalized name: acetaminophen 650 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen 650 mg every 6 hours for 3 days
Trial: 21116816
Drug: Fluvastatin 80
RxNorm normalized name: fluvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 80 mg single dose prior to ZOL infusion
Trial: 15291677
Drug: Olanzapine-Fluoxetine Combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine-Fluoxetine Combination (OFC)
Trial: 15291677
Drug: Control (Fluoxetine)
RxNorm normalized name: Afeditab CR
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control (Fluoxetine)
Trial: 30341143
Drug: Combined steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined steroid and mycophenolate mofetil (MMF)
Trial: 30341143
Drug: Standard steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard steroid treatment
Trial: 18797832
Drug: Early orthodontic
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early orthodontic treatment (bonded palatal expansion appliance and U-bow activator)
Trial: 12812627
Drug: Routine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine treatment (without CRRT)
Trial: 10450833
Drug: Enalapril (ENA),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (ENA), 10 mg o.d.
Trial: 10450833
Drug: Nitrendipine (NIT),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine (NIT), 20 mg o.d.
Trial: 29956318
Drug: Titration method
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Titration method
Trial: 25088637
Drug: HSM IOL
RxNorm normalized name: iodine iolopride (123I)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HSM IOL (heparin-surface-modified hydrophobic acrylic intraocular lens)
Trial: 20370727
Drug: Yun-chang capsule
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Yun-chang capsule 70 mg plus placebo 35 mg (group A)
Trial: 20370727
Drug: Yun-chang capsule
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Yun-chang capsule 105 mg (group B)
Trial: 20370727
Drug: Placebo 105
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo 105 mg (group C)
Trial: 17646514
Drug: Topical EMLA
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical EMLA cream 60 min before block plus 2 mL IV normal saline 5 min before procedure
Trial: 17646514
Drug: Topical sham
RxNorm normalized name: soap TOPICAL SHAMPOO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical sham cream plus 2 mL IV normal saline
Trial: 17646514
Drug: Topical sham
RxNorm normalized name: soap TOPICAL SHAMPOO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical sham cream plus 0.1 microg/kg of sufentanil in 2 mL solution IV
Trial: 16114181
Drug: Vanillin treatment
RxNorm normalized name: Vanillin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vanillin treatment
Trial: 2066644
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose octreotide (200 micrograms)
Trial: 2066644
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose octreotide (400 micrograms)
Trial: 2066644
Drug: Octreotide infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide infusion (both doses)
Trial: 6646402
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg of lorazepam (Ativan)
Trial: 28962602
Drug: SDT‐WL (Self-Determination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SDT‐WL (Self-Determination Theory-based Weight Loss Treatment)
Trial: 28962602
Drug: BWL (Standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BWL (Standard Behavioral Weight Loss Treatment)
Trial: 12324552
Drug: Warfarin (INR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin (INR 2.8 to 4.2)
Trial: 12324552
Drug: Warfarin (INR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin (INR 2.0 to 2.5) and Aspirin (75 mg daily)
Trial: 12324552
Drug: Warfarin (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin (both dosages)
Trial: 10589612
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (TA) - IV infusion of 15 mg/kg over 30 min, followed by 10 mg x kg(‐1) x hr(‐1) for 12 hours
Trial: 10589612
Drug: Normovolemic hemodilution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normovolemic hemodilution (NVHD) - blood removed to target hematocrit of approximately 28%, maintained with lactated Ringer's solution
Trial: 1862210
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg oral test dose of haloperidol (HPDL)
Trial: 1862210
Drug: Empirically determined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empirically determined doses of HPDL (2, 4, or 10 mg b.i.d.)
Trial: 24756766
Drug: Methylphenidate (Ritalin),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (Ritalin), a catecholamine reuptake blocker, dosage and duration not specified
Trial: 15915401
Drug: Etomidate (0.10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etomidate (0.10 mg/kg)
Trial: 15915401
Drug: Midazolam (0.035
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.035 mg/kg)
Trial: 12595862
Drug: Soy protein
RxNorm normalized name: Soy Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy protein (25 g daily for 6 weeks)
Trial: 3907987
Drug: pivmecillinam plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pivmecillinam plus pivampicillin (200 mg pivmecillinam plus 250 mg pivampicillin)
Trial: 3907987
Drug: co-trimoxazole (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: co-trimoxazole (800 mg sulphamethoxazole plus 160 mg trimethoprim)
Trial: 30101646
Drug: Fist Assist®
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fist Assist® device (intermittent pneumatic compression) worn 6 hours daily for 30 days.
Trial: 26478225
Drug: TPTD 56.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TPTD 56.5 μg
Trial: 23032083
Drug: Eicosapentaenoic acid
RxNorm normalized name: eicosapentaenoic acid
DrugBank: Icosapent (DB00159)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eicosapentaenoic acid (EPA) 2700 mg/day from day after surgery until day 30
Trial: 22777865
Drug: ODN 50
RxNorm normalized name: ODN M362
DrugBank: ODN M362 (DB16485)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ODN 50 mg
Trial: 22777865
Drug: Placebo (after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (after switching from ODN 50 mg)
Trial: 22777865
Drug: Continuous ODN
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous ODN (10-50 mg)
Trial: 22777865
Drug: Switched from
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Switched from ODN (10-50 mg) to placebo after 2 years
Trial: 22777865
Drug: ODN (10-50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ODN (10-50 mg) for 5 years
Trial: 22777865
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of ODN
Trial: 19709169
Drug: Chemotherapy treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy treatment for cancer
Trial: 19709169
Drug: Subset of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subset of chemotherapy-treated adults
Trial: 20350302
Drug: LY450139 (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LY450139 (100 mg)
Trial: 20350302
Drug: LY450139 (140
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LY450139 (140 mg)
Trial: 15923270
Drug: Conventional 'fascial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional 'fascial click' method using levobupivacaine 0.25% (0.3 ml kg(‐1))
Trial: 10553847
Drug: Intrathecal 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal 2.5 microg sufentanil, 1.25 mg bupivacaine, 25 microg epinephrine
Trial: 10553847
Drug: Intrathecal 5
RxNorm normalized name: ZICONOTIDE 100MCG/ML INJ INTRATHECAL 5ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal 5 microg sufentanil, 1.25 mg bupivacaine, 25 microg epinephrine
Trial: 10553847
Drug: Control group:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group: 1.25 mg bupivacaine, 25 microg epinephrine
Trial: 26192386
Drug: Behavior activation
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavior activation therapy
Trial: 26070195
Drug: Standard Treatment
RxNorm normalized name: Azo-Standard
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard Treatment (ST) for 12 weeks (n=22)
Trial: 23515409
Drug: Chemotherapy +
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy + Zoledronic Acid (ZOL)
Trial: 19802403
Drug: Intravenous (iv)
RxNorm normalized name: intravenous (IV) infusion pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (iv) outpatient treatment with amikacin or ceftriaxona, followed by oral antimicrobial after urine culture results, duration of iv treatment 2.9 days (SD 1.9)
Trial: 19802403
Drug: Intravenous (iv)
RxNorm normalized name: intravenous (IV) infusion pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (iv) inpatient treatment with amikacin or ceftriaxona, followed by oral antimicrobial after urine culture results, duration of iv treatment 2.8 days (SD 1.2)
Trial: 17113895
Drug: Increased fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased fluid intake (1.5 L of extra water daily)
Trial: 17113895
Drug: Placebo (one
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (one tablespoon of placebo syrup daily)
Trial: 8087329
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (BDP) 200 micrograms twice per day for 2 weeks
Trial: 8087329
Drug: Budesonide (BUD)
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide (BUD) 200 micrograms twice per day for 2 weeks
Trial: 2676000
Drug: (2"R)-4'-O-tetrahydropyranyladriamycin (THP)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (2"R)-4'-O-tetrahydropyranyladriamycin (THP) in combination with 5-fluorouracil (5-FU) and cyclophosphamide (CPA)
Trial: 2676000
Drug: Adriamycin (ADR)
RxNorm normalized name: Adriamycin
DrugBank: Doxorubicin (DB00997)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adriamycin (ADR) in combination with 5-fluorouracil (5-FU) and cyclophosphamide (CPA)
Trial: 12932592
Drug: AF Suppression
RxNorm normalized name: Canesten AF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AF Suppression Algorithm (treatment group)
Trial: 11231208
Drug: Combined hepatitis
RxNorm normalized name: hepatitis nosodes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined hepatitis A and typhoid fever vaccine (25 microg typhoid Vi polysaccharide and at least 1,440 ELISA units of inactivated hepatitis A in a 1 mL dose)
Trial: 11231208
Drug: Combined hepatitis
RxNorm normalized name: hepatitis nosodes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined hepatitis A and typhoid fever vaccine
Trial: 2221314
Drug: High-dose fentanyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose fentanyl (0.05 mg/kg) and pancuronium (0.1 mg/kg)
Trial: 2221314
Drug: Balanced anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balanced anesthesia with 0.02 mg/kg flunitrazepam, N2O/O2 1:1, isoflurane 0.5 vol%, and pancuronium (0.1 mg/kg) with a bolus of 0.005 mg/kg fentanyl
Trial: 31759771
Drug: Simo decoction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simo decoction 20 ml q8h for 24 h
Trial: 31759771
Drug: Domperidone suspension
RxNorm normalized name: Domperidone
DrugBank: Domperidone (DB01184)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone suspension 20 mg/20 ml q6h for 24 h
Trial: 19581631
Drug: Stepped-dose efavirenz
RxNorm normalized name: Efavirenz
DrugBank: Efavirenz (DB00625)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Stepped-dose efavirenz (200 mg/d on days 1-6, 400 mg/d on days 7-13, 600 mg/d from day 14)
Trial: 19581631
Drug: Full-dose efavirenz
RxNorm normalized name: Efavirenz
DrugBank: Efavirenz (DB00625)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Full-dose efavirenz (600 mg/d from day 1)
Trial: 19581631
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (Stepped-dose and Full-dose)
Trial: 17472846
Drug: Heparin-coated polyacrylonitrile
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-coated polyacrylonitrile membrane (AN69ST)
Trial: 7648641
Drug: Antibiotic prophylaxis
RxNorm normalized name: STONE PROPHYLAXIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic prophylaxis during perioperation
Trial: 7648641
Drug: Routine use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine use of antibiotics as usual (Control)
Trial: 2686258
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg isosorbide dinitrate (ISDN)
Trial: 7957511
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg isosorbide dinitrate (ISDN)
Trial: 2686258
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg isosorbide dinitrate (ISDN)
Trial: 2686258
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg ISDN + 25 mg gallopamil (G)
Trial: 2686258
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg ISDN + 50 mg gallopamil (G)
Trial: 2686258
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg ISDN + 80 mg propranolol (P)
Trial: 2686258
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg ISDN + 25 mg gallopamil (G)
Trial: 2686258
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg ISDN + 50 mg gallopamil (G)
Trial: 2686258
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg ISDN + 80 mg propranolol (P)
Trial: 2686258
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg ISDN + 25 mg gallopamil (G)
Trial: 2686258
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg ISDN + 50 mg gallopamil (G)
Trial: 2686258
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg ISDN + 80 mg propranolol (P)
Trial: 7388119
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg pyridoxine per day
Trial: 7388119
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg pyridoxine per day
Trial: 7388119
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g pyridoxine per day
Trial: 27913066
Drug: Betamethasone‐17‐valerate cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betamethasone‐17‐valerate cream
Trial: 27913066
Drug: Essex® cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Essex® cream (moisturizer)